作者: Torsten Liersch , Marian Grade , Jochen Gaedcke , Sudhir Varma , Michael J. Difilippantonio
DOI: 10.1016/J.CANCERGENCYTO.2008.11.011
关键词:
摘要: Preoperative chemoradiotherapy is recommended for locally advanced rectal cancer (UICC stage II/III). We recently demonstrated that responsive and nonresponsive tumors showed differential expression levels of 54 genes. In this follow-up study, we investigated the relationship between gene set disease-free (DFS) overall survival (OS). Pretherapeutic biopsies from 30 participants in CAO/ARO/AIO-94 trial German Rectal Cancer Study Group were analyzed using microarrays. Statistical analysis was performed to identify differentially expressed genes recurrent nonrecurrent correlate these changes with disease recurrence outcome. After a median 59 months, seven eight patients nonresponder, one tumor recurred. Response significantly correlated an improved DFS (log rank P=0.028), whereas OS did not differ (P=0.11). Applying class comparison analysis, identified 20 (P<0.001). Analyzing first two principal components previously predict response, observed response signature increased risk recurrence. These data suggest genetic basis local also affects Genes are indicative nonresponse preoperative might be linked